Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma

por Adamia, Sophia, Bhatt, Shruti, Wen, Kenneth, Chyra, Zuzana, Fell, Geoffrey G., Tai, Yu-Tzu, Pioso, Marissa S., Abiatari, Ivane, Letai, Anthony, Dorfman, David M., Hideshima, Teru, Anderson, Kenneth C.
Publicado 2022

STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade

por Varikuti, Sanjay, Oghumu, Steve, Elbaz, Mohamad, Volpedo, Greta, Ahirwar, Dinesh K., Alarcon, Pablo C., Sperling, Rachel H., Moretti, Ellen, Pioso, Marissa S., Kimble, Jennifer, Nasser, Mohd W., Ganju, Ramesh K., Terrazas, Cesar, Satoskar, Abhay R.
Publicado 2017

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML

por Drenberg, Christina D., Shelat, Anang, Dang, Jinjun, Cotton, Anitria, Orwick, Shelley J., Li, Mengyu, Jeon, Jae Yoon, Fu, Qiang, Buelow, Daelynn R., Pioso, Marissa, Hu, Shuiying, Inaba, Hiroto, Ribeiro, Raul C., Rubnitz, Jeffrey E., Gruber, Tanja A., Guy, R. Kiplin, Baker, Sharyn D.
Publicado 2019